BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 908845)

  • 21. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiographic measurement of topical corticosteroid-induced atrophy.
    Snyder DS; Greenberg RA
    J Invest Dermatol; 1977 Sep; 69(3):279-81. PubMed ID: 330766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative changes in the function of muscle ribosomes and mitochondria during the early phase of steroid-induced catabolism.
    Bullock GR; Carter EE; Elliott P; Peters RF; Simpson P; White AM
    Biochem J; 1972 May; 127(5):881-92. PubMed ID: 5076236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the effectiveness of locally administered corticosteroids].
    Semrádová V; Horácek J
    Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
    [No Abstract]   [Full Text] [Related]  

  • 26. Penetration of various corticosteroids through epidermis in vitro.
    Ponec M; Polano MK
    Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems in selection of topical anti-inflammatory corticosteroids.
    Stewart WD; Runikis JO; Verma SC; Wallace S
    Can Med Assoc J; 1973 Jan; 108(1):33-8. PubMed ID: 4682636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid.
    Phillips BM; Sanen FJ; Leeling JL; Hammes TL; Hartnagel RE; Sancilio LF; Lorenzetti OJ; Kraus PJ
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):522-37. PubMed ID: 5143593
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid inhibition of oedema formation in the rat skin.
    Ahluwalia A; Peers SH; Flower RJ
    Br J Pharmacol; 1992 Jul; 106(3):628-31. PubMed ID: 1504745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucocorticosteroids on primary human skin fibroblasts. II. Effects on total protein and collagen biosynthesis by confluent cell cultures.
    Ponec M; Hasper I; Vianden GD; Bachra BN
    Arch Dermatol Res (1975); 1977 Aug; 259(2):125-34. PubMed ID: 907362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glucocorticosteroids on primary human skin fibroblasts. I. Inhibition of the proliferation of cultured primary human skin and mouse L929 fibroblasts.
    Ponec M; de Haas C; Bachra BN; Polano MK
    Arch Dermatol Res (1975); 1977 Aug; 259(2):117-23. PubMed ID: 907361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to the rebound phenomenon.
    Go MJ; Wuite J
    Dermatologica; 1976; 152 Suppl 1():239-46. PubMed ID: 133841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroid-induced inhibition of the biosynthesis of human skin collagen.
    Uitto J; Teir H; Mustakallio KK
    Biochem Pharmacol; 1972 Aug; 21(16):2161-7. PubMed ID: 4646188
    [No Abstract]   [Full Text] [Related]  

  • 36. A study of potential skin atrophy following topical application of weak corticosteroids.
    Black MM; Platt NE; Mugglestone CJ
    Curr Med Res Opin; 1981; 7(7):463-70. PubMed ID: 7261664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [DNA-synthesis and hyperplasia of the epidermis after stripping and application of ointments].
    Christophers E
    Arch Klin Exp Dermatol; 1968; 233(3):277-86. PubMed ID: 5729263
    [No Abstract]   [Full Text] [Related]  

  • 38. [Development and regression of dermal corticosteroid atrophy. 4. Concentration dependence of the skin thinning effect of triamcinolone acetonide].
    Lütgemeier MD; Lubach D
    Derm Beruf Umwelt; 1987; 35(2):55-7. PubMed ID: 2954806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of topically applied steroidal and nonsteroidal anti-inflammatory agents on skin repair and regeneration.
    Alvarez OM; Levendorf KD; Smerbeck RV; Mertz PM; Eaglstein WH
    Fed Proc; 1984 Oct; 43(13):2793-8. PubMed ID: 6207052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response effects of tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues on glucocorticoid-induced skin atrophy in the haired mouse.
    Faergemann J; Särnhult T; Hedner E; Carlsson B; Lavin T; Zhao XH; Sun XY
    Acta Derm Venereol; 2002; 82(3):179-83. PubMed ID: 12353707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.